NuVasive has received premarket approval of its PCM Cervical Disc System from the FDA.
The PCM Cervical Disc is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from C3-C4 to C6-C7. The device is implanted using an anterior approach. Patients should have failed at least six weeks of conservative treatment prior to implantation.
More Articles on Orthopedic Devices: New Instrumentation & Partnership for DePuy Synthes Spine
DePuy Synthes Spine Launches Minimally Invasive Posterior-Lateral Fusion System
10 Orthopedic Device Company Acquisitions